Recombinant growth hormone accelerates regenerate consolidation in distraction osteogenesis

Citation
Mj. Raschke et al., Recombinant growth hormone accelerates regenerate consolidation in distraction osteogenesis, CHIRURG, 71(9), 2000, pp. 1009-1015
Citations number
30
Categorie Soggetti
Surgery
Journal title
CHIRURG
ISSN journal
00094722 → ACNP
Volume
71
Issue
9
Year of publication
2000
Pages
1009 - 1015
Database
ISI
SICI code
0009-4722(200009)71:9<1009:RGHARC>2.0.ZU;2-V
Abstract
Distraction osteogenesis is a good model for evaluation of fracture healing with intramembranous bone formation. The purpose of the present study was to investigate whether homologous GH has a stimulating effect on bone heali ng in distraction osteogenesis. The left tibiae of 30 micropigs were osteom ized and distracted with an external fixator 2 mm daily over a period of 10 days. Animals were killed after an additional healing time of 10 days. The treatment group received 100 mu g r-pGH per kg bodyweight per day. A newly developed device allowed non-destructive torsional biomechanical evaluatio n of the regenerate strength as in vivo measurements. After killing, destru ctive torsional strength testing of the sites of distraction was performed. To determine the endocrine response to the administration of r-pGH, serum levels of IGF-I were determined. The non-destructive in vivo testing showed that torsional stiffness of the regenerate was significantly higher in the treatment group than in the control group. Final regenerate torsional fail ure load was 131 % higher and ultimate torsional stiffness was 231 % higher in the treatment group than in the control group. The mean serum level of IGF-I increased to 440 % of the preoperative base level in the treatment gr oup and remained unchanged in the control group. Our data indicate that sys temic administration of recombinant homologous growth hormone significantly accelerates ossification of bone regenerate in distraction osteogenesis.